Downmodulation of CXCL8/IL-8 receptors on neutrophils after recruitment in the airways.

[1]  R. Atmar,et al.  Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[2]  S. Foster,et al.  Selective Roles for Toll-Like Receptor (TLR)2 and TLR4 in the Regulation of Neutrophil Activation and Life Span1 , 2003, The Journal of Immunology.

[3]  J. Koziol,et al.  Bradykinin increases the in vivo expression of the CXC chemokine receptors CXCR1 and CXCR2 in patients with allergic rhinitis. , 2003, Journal of Allergy and Clinical Immunology.

[4]  Lin Ying Liu,et al.  Decreased Expression of Membrane IL-5 Receptor α on Human Eosinophils: I. Loss of Membrane IL-5 Receptor α on Airway Eosinophils and Increased Soluble IL-5 Receptor α in the Airway After Allergen Challenge1 , 2002, The Journal of Immunology.

[5]  H. Sarau,et al.  A Potent and Selective Nonpeptide Antagonist of CXCR2 Inhibits Acute and Chronic Models of Arthritis in the Rabbit1 , 2002, The Journal of Immunology.

[6]  B. Balbi,et al.  Is dithiothreitol affecting cells and soluble mediators during sputum processing? A modified methodology to process sputum. , 2002, The Journal of allergy and clinical immunology.

[7]  J. Douwes,et al.  Non-eosinophilic asthma: importance and possible mechanisms , 2002, Thorax.

[8]  J. Gordon,et al.  CXCL8((3-73))K11R/G31P antagonizes ligand binding to the neutrophil CXCR1 and CXCR2 receptors and cellular responses to CXCL8/IL-8. , 2002, Biochemical and biophysical research communications.

[9]  K. J. Macleod,et al.  Association of forced expiratory volume with disease duration and sputum neutrophils in chronic asthma. , 2002, The American journal of medicine.

[10]  P. O'Byrne,et al.  Increased levels of airway neutrophils reduce the inhibitory effects of inhaled glucocorticosteroids on allergen-induced airway eosinophils. , 2002, Canadian respiratory journal.

[11]  P. Gibson,et al.  Heterogeneity of airway inflammation in persistent asthma : evidence of neutrophilic inflammation and increased sputum interleukin-8. , 2001, Chest.

[12]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[13]  K. Chung,et al.  Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response , 2000, The Lancet.

[14]  A. Spanevello,et al.  Induced sputum cellularity. Reference values and distribution in normal volunteers. , 2000, American journal of respiratory and critical care medicine.

[15]  C. O'connor,et al.  Interleukin-8 and leukotriene-B(4), but not formylmethionyl leucylphenylalanine, stimulate CD18-independent migration of neutrophils across human pulmonary endothelial cells in vitro. , 2000, American journal of respiratory cell and molecular biology.

[16]  K. Chung,et al.  Neutrophilic inflammation in severe persistent asthma. , 1999, American journal of respiratory and critical care medicine.

[17]  S. Wenzel,et al.  Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. , 1999, American journal of respiratory and critical care medicine.

[18]  W. Tan,et al.  Dithiothreitol has a dose-response effect on cell surface antigen expression. , 1999, The Journal of allergy and clinical immunology.

[19]  D. Kelvin,et al.  Metalloproteinases are involved in lipopolysaccharide- and tumor necrosis factor-alpha-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression. , 1999, Blood.

[20]  K. Steinberg,et al.  Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis. , 1999, Journal of immunology.

[21]  Simon A. Jones,et al.  Granulocyte chemotactic protein 2 acts via both IL‐ 8 receptors, CXCR1 and CXCR2 , 1998, European journal of immunology.

[22]  P. Proost,et al.  Interleukin-8 and other CXC chemokines , 1998 .

[23]  A. Chuntharapai,et al.  Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor. , 1995, Journal of immunology.

[24]  Kwang Woo Kim,et al.  Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. , 1995, The Journal of allergy and clinical immunology.

[25]  G. Gleich,et al.  Sudden-onset fatal asthma. , 1994, Mayo Clinic proceedings.

[26]  A. Thomson.  The cytokine handbook , 1994 .

[27]  C E Reed,et al.  Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? , 1993, The American review of respiratory disease.

[28]  Alfred O. Berg,et al.  Clinical Guidelines And Primary Care Guidelines For The Diagnosis And Management Of Asthma , 2012 .

[29]  W I Wood,et al.  Structure and functional expression of a human interleukin-8 receptor. , 1991, Science.

[30]  K. Matsushima,et al.  Interleukin 8 (monocyte-derived neutrophil chemotactic factor) dynamically regulates its own receptor expression on human neutrophils. , 1990, The Journal of biological chemistry.